| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |